Logo Logo
Hilfe
Hilfe
Switch Language to English

Bergmann, Michele; Holzheu, Mike; Zablotski, Yury; Speck, Stephanie; Truyen, Uwe und Hartmann, Katrin (2021): Evaluation of a Point-of-Care Test for Pre-Vaccination Testing to Detect Antibodies against Canine Adenoviruses in Dogs. In: Viruses-Basel, Bd. 13, Nr. 2, 183

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

(1) Background: Antibody testing is commonly used to assess a dog's immune status. For detection of antibodies against canine adenoviruses (CAVs), one point-of-care (POC) test is available. This study assessed the POC test ' s performance. (2) Methods: Sera of 198 privately owned dogs and 40 specific pathogen-free (SPF) dogs were included. The reference standard for detection of anti-CAV antibodies was virus neutralization (VN) using CAV-1 and CAV-2 antigens. Specificity, sensitivity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy (OA) of the POC test were assessed. Specificity was considered most important. (3) Results: Prevalence of CAV-1 neutralizing antibodies (>= 10) was 76% (182/238) in all dogs, 92% (182/198) in the subgroup of privately owned dogs, and 0% (0/40) in SPF dogs. Prevalence of CAV-2 neutralizing antibodies (>= 10) was 76% (181/238) in all dogs, 91% (181/198) in privately owned dogs, and 0% (0/40) in SPF dogs. Specificity for detection of CAV-1 antibodies was lower (overall dogs, 88%;privately owned dogs, 56%;SPF dogs, 100%) compared with specificity for detection of CAV-2 antibodies (overall dogs, 90%;privately owned dogs, 65%;SPF dogs, 100%). (4) Conclusions: Since false positive results will lead to potentially unprotected dogs not being vaccinated, specificity should be improved to reliably detect anti-CAV antibodies that prevent infectious canine hepatitis in dogs.

Dokument bearbeiten Dokument bearbeiten